Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk

1875-Breast trastuzumab subcutaneous trastuzumab

Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of

trastuzumab Trastuzumab is a monoclonal antibody targeted against the HER2 tyrosine kinase receptor The majority of patients with metastatic breast Possible Side Effects of Trastuzumab · Heart Problems · Infusion-Related Side Effects · Lung Problems · Low White Blood Cell Count (Leukopenia Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2 Annotated peptide sequences for this antibody are available from its IMGTmAb-DB

yamaha มอเตอร์ไซค์ Trastuzumab emtansine binds to the HER2 receptor's sub-domain IV and goes into the cell by receptor-mediated endocytosis Lysosomes degrade trastuzumab